Affinity adds Vanquish - a new non-surgical fat reduction treatment

It’s Spring and we all want to look good this summer for the pool or beach. It is not surprising that February through May are very busy times in our office for non-surgical fat reduction techniques Vanquish. But what, exactly, is Vanquish?

Vanquish, our latest non-surgical fat reduction device is FDA cleared for tissue heating, which is a known form of fat reduction. Instead of cryolipolysis (freezing), Vanquish utilizes radio frequency technology to heat and reduce fat. Unlike other techniques, in which the applicator comes in direct contact with the skin, with Vanquish the patient lies under the device while the sensors read your body fat to determine the energy level needed. The focused-field radio frequency heats the skin to 101 degrees and the underlying fat to 120 degrees to help eliminate fat cells. The treatment takes about 30 minutes and patients typically have 4 sessions spaced one week apart. The destroyed fat cells are eliminated naturally by the body.

Vanquish has a large applicator, which may provide more uniform fat reduction. Once the device is placed over the treatment area, most patients feel quite warm, and at times, a bit sleepy. A trained professional stays with the patient throughout the treatment process in case the area begins to feel too warm or needs to be adjusted. It is important to be very well hydrated prior to the treatment.

According to a study performed by BTL Aesthetics, after 4-6 weekly treatment sessions, patients report up to 59% reduction in fat at the treated site as contrasted to the 20-22% offered by other similar devices. Vanquish results tend to be realized a little earlier than those with similar treatments and results are more uniform.

If you are one of the many people who want to start out the summer in better shape, there are some great options to help you jump start your resolutions and reduce the fat. For more information about Vanquish, please contact Monica Landsman for a private consultation.